- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Gray accepts VP position with Trex Medical
Trex Medical has hired Dr. Joel Gray as vice president of business and clinical development. Gray was hired for his imaging expertise as the company prepares for premarket approval of its full-field digital mammography system this year, said
Trex Medical has hired Dr. Joel Gray as vice president of business and clinical development. Gray was hired for his imaging expertise as the company prepares for premarket approval of its full-field digital mammography system this year, said William Webb, Trex president and CEO.
Gray will oversee the final stages of development of Lorads digital mammography unit. Lorad is Trexs mammography division.
Gray was a medical physicist in the Mayo Clinics radiology department for 20 years. For the past four years, he has been an independent consultant in medical technology management and assessment, medical physics, and imaging sciences for healthcare organizations and the medical imaging industry. He also worked with several overseas organizations to promote quality medical imaging.
Trex Medical, owned by Thermo Electron, is up for sale. Thermo Electron announced earlier this year it would seek a buyer.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
